JF
Insider
Jonathan C Fox
DirectorJonathan C Fox (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Edgewise Therapeutics, Inc. (EWTX). Across 1 priced purchase filing, the average 21-session return was +29.9% from execution and +11.9% from disclosure (delay-adjusted; derived). The largest single filing was $199K of EWTX (10,700 sh × $18.64, as filed), executed Nov 11 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+29.9%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+11.9%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$199K
shares × price, as filed
Last traded
Nov 11 2025
Filed Nov 13 2025
Median ADV $64.2M across their filed names
Open performance→Volume by month
Buys $199K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
EWTXRecent filings
EWTXPURCHASE
Edgewise Therapeutics, Inc.
View filing →
$199K10,700 sh × $18.64
Exec Nov 11 2025
Filed Nov 13 2025 · 6:04 PM ET